The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
In other words, the Prime Minister will say that leaving the EU would not lead to a single EU law being abolished instantly.
Reclaim the Power stage a protest at Heathrow against a new runway or further airport expansion.
A colder night ahead as temperatures fall.